Johnson & Johnson (J&J) COVID-19 vaccine dose.
Photo: PHILL MAGAKOE / AFP / Getty Images
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are recommending that the United States stop use of Johnson & Johnson’s Covid-19 vaccine after six cases reported in the country of a “rare and serious” type of blood clot.
The six reported cases are among the more than 6.8 million doses of Johnson & Johnson vaccine administered so far in the United States and occurred in women 18 to 48 years old, 6 to 13 days after dosing, according a joint statement issued today at 7 am by Dr. Anne Schuchat, CDC Senior Deputy Director; and Dr. Peter Marks, director of the FDA’s Center for Biologics Research and Evaluation.
“CDC will convene an Advisory Committee on Immunization Practices (ACIP) meeting on Wednesday (morning) to review these cases further and assess their potential importancel, ”the statement said, quoted by CNN.
“The FDA will review that analysis, as it is also investigating these cases. Until the process is complete, we recommend a pause in the use of this vaccine as a precaution. This is important, in part, to ensure that the healthcare provider is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot. “
The vaccine Johnson & Johnson has become very popular, in cities like New York, for the convenience that it only requires a single application, Unlike the two doses recommended by the Pfizer and Moderna laboratories, the others authorized in the country under the category of “emergency” due to the coronavirus pandemic.
At 7 am, CDC & FDA issued this statement pic.twitter.com/7QPG144PA7
– Carl Zimmer (@carlzimmer) April 13, 2021
If you like the information we shared in this article, please like, follow, share and subscribe us on Facebook, Twitter, Tumblr and Instagram so that we can share more such useful articles with you in future.